Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions
Author:
Publisher
Wiley
Subject
Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1999.tb00777.x/fullpdf
Reference16 articles.
1. Comparison of needle biopsy with cytological analysis for the evaluation of pleural effusion: analysis of 414 cases;Prakash;Mayo Clin Proc,1985
2. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy;Ryan;Mayo Clin Proc,1981
3. Markers of non-small cell lung cancer;Pujol;Tumour Marker Update,1990
4. CYFRA 21-1 Enzyme-Linked Immunosorbent Assay. Evaluation as a tumor marker in non-small cell lung cancer;Lai;Chest,1996
5. CYFRA 21-1 - clinical applications and analytical requirements;Ebert;Scan J Clin Lab Invest,1995
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The diagnostic value of CEA for lung cancer-related malignant pleural effusion in China: a meta-analysis;Expert Review of Respiratory Medicine;2021-06-24
2. Experience in medical thoracoscopy: a 4-year retrospective study;Egyptian Journal of Bronchology;2019-02-13
3. Pleural Effusions in Lung Cancer: Detection and Treatment;Lung Cancer - Strategies for Diagnosis and Treatment;2018-10-31
4. Biomarkers in Malignant Mesothelioma: Diagnostic and Prognostic Role of Soluble Mesothelin-Related Peptide;The International Journal of Biological Markers;2011-07
5. Soluble markers for diagnosis of malignant pleural mesothelioma;Biomarkers in Medicine;2011-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3